Article thumbnail
Location of Repository

Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores

By Martina Schobesberger, Anna Baltzer, Andrea Oberli, Andreas Kappeler, Mathias Gugger, Hana Burger and Rolf Jaggi
Topics: Technical Advance
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2596175
Provided by: PubMed Central

Suggested articles

Citations

  1. (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
  2. (2001). Cordon-Cardo C: Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest
  3. (2008). Expression profiling with RNA from formalin-fixed, paraffin-embedded material. BMC Med Genomics
  4. (2003). Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA
  5. (2005). HJ: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol
  6. (2008). IO: Expression profiling technology: its contribution to our understanding of breast cancer. Histopathology
  7. (2001). IO: Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team. Eur J Surg Oncol
  8. (1998). Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med
  9. (2006). Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy. Clin Cancer Res
  10. (2007). Musholt PB: Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1–12 transcripts.
  11. (2006). Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res
  12. (2005). Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest
  13. (2000). Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest
  14. (2007). Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer
  15. (2002). Tissue microarrays for miniaturized highthroughput molecular profiling of tumors. Exp Hematol
  16. (2001). Tissue microarrays for rapid linking of molecular changes to clinical endpoints.
  17. (2007). Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology. Head Neck

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.